Study of a new drug in healthy men
This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy man between 18 and 45 years old.
- Your weight must be at least 50 kilograms (about 110 pounds).
- You must be in good health overall, with no major medical conditions.
- You cannot smoke more than 5 cigarettes a day on average, and you must be willing to stop smoking during the trial.
- You cannot drink more than 14 units of alcohol per week on average.
- You must not have taken any prescription or over-the-counter medications in the 2 weeks before the trial starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study gives healthy people a single shot of a study drug that has a tiny radioactive label, then tracks how it moves through the body. It helps researchers learn how the drug is absorbed and removed, which is a key step before it can be tested as a possible treatment for weight-related conditions.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
This study examines how a new drug (called HRS-1780) is processed and eliminated by the body using a special radioactive label. It will help researchers understand the drug’s behavior to guide future studies.
Hear when a new Healthy Subjects (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.